17 April 2024
Transense Technologies plc
("Transense" or "the Company")
Transaction in own shares
Change to Total Voting Rights
Transense Technologies plc, the provider of specialist sensor technology and measurement systems, announces that on 17 April 2024, the Company purchased 15,000 of its own ordinary shares of 10 pence each ("Ordinary Shares") at a price of 91 pence per share. These shares will be held in treasury for the time being to satisfy share option awards in the future.
Following these transactions, the total number of Ordinary Shares held as treasury shares by the Company is 1,217,856. The total number of Ordinary Shares in issue (including shares held as treasury shares) is 16,437,740. Therefore, the total number of voting rights in the Company is 15,219,884 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, the information below contains information about the purchases made by Shard Capital Stockbrokers on behalf of the Company as part of the buyback programme.
Aggregate information:
| Shares purchased: | Transense Technologies plc (ISIN CODE: GB00BDHDTH21) |
| Date of purchases: | 17 April 2024 |
| Investment firm | Shard Capital Stockbrokers |
| Venue | London Stock Exchange |
| Number of ordinary shares purchased | 15,000 |
| Volume-weighted average price, pence | 91 |
| Highest price paid (per ordinary share), pence | 91 |
| Lowest price paid (per ordinary share), pence | 91 |
For further information please visit www.transense.com or contact:
| Transense Technologies plc Nigel Rogers (Executive Chairman) Melvyn Segal (CFO) | Via Walbrook PR |
| Allenby Capital (Nominated Adviser and Broker) Jeremy Porter / George Payne (Corporate Finance) Stefano Aquilino / Tony Quirke (Sales & Corporate Broking) | Tel: +44 (0)20 3328 5656 |
| Walbrook PR Tom Cooper/Nick Rome / Joseph Walker | Tel: +44 (0)20 7933 8780 Transense@walbrookpr.com |
Notes to Editors:
Transense is a developer of specialist sensor technology and measurement systems. The Company has two active business divisions:
· Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety; and
· SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery.
In addition, the Company earns residual royalty income from Bridgestone iTrack (new branding name for iTrack), a tyre condition and performance monitoring system, that was developed by Translogik and subsequently licensed to Bridgestone Corporation for a ten year period in 2020, expiring in 2030.
The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from its business divisions by leveraging excellence in innovation and know-how to commercialise technologies through industry partnerships and exposure to global growth markets.
Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com
For further information please contact transense@walbrookpr.com
Schedule of Purchases - Individual Transactions
| Number of Shares | Price Per Share (pence) | Trading Venue | Date of Transaction | Time of transaction |
| 15,000 | 91 | London Stock Exchange | 17 April 2024 | 15:12:00 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.